VIE/GALE (VIE/GALE)

Vienna Stock Exchange: VIE/GALE · EUR

€95.8

+0.75 (+0.8%)· Recorded snapshot

Market cap	4.7B
Revenue (ttm)	4.6B
Net income (ttm)	172.4M
EPS (ttm)	€3.46
P/E (trailing)	27.7x
P/E (forward)	21.8x
Dividend	€2.72 (2.84%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4.6B
Net income (ttm): 172.4M
EPS (ttm): €3.46
P/E (trailing): 27.7x
P/E (forward): 21.8x
Market cap: 4.7B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E21.8

P25 14.3P50 18.7P75 25.4

Trailing P/E27.7

P25 20.4P50 26.7P75 39.7

ROE11.4

P25 4.8P50 10.6P75 20.1

ROIC6.8

P25 5.8P50 9.5P75 18.2

All VIE/GALE indicators

Market & fundamental data

Available fields

227

Groups with data

Currency

CHF

Showing 227 of 227 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Switzerland
Country code	AT
Earnings date	2027-03-09
Employees	6,623
Employees change	456
Employees growth	5.72%
Enterprise value	EUR 5.9B
Exchange	Vienna Stock Exchange
Financial currency	CHF
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1927
Industry	Medical Distribution
Is primary listing	No
ISIN number	CH0360674466
Last earnings date	2026-08-06
Last refreshed	2026-10-29
Market cap	EUR 4.7B
Next earnings date	2027-03-09
Price	EUR 95.80
Price currency	EUR
Sector	Healthcare
SIC code	5122
Stock price date	2026-10-28
Symbol	vie/GALE
Website	https://www.galenica.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	20.15x
Average P/E ratio (3Y)	20.76x
Average P/E ratio (5Y)	20.25x
Earnings yield	3.61%
EV/Earnings	34.19x
EV/EBIT	25.72x
EV/EBITDA	17.05x
EV/FCF	24.74x
EV/Sales	1.27x
FCF / EV yield	4.04%
FCF yield	5.03%
Forward P/E	21.84x
Graham number	49.31899
Graham upside	-48.52%
Lynch fair value	EUR 17.44
Lynch upside	-81.8%
P/(FCF - SBC) ratio	20.55x
P/(OCF - SBC) ratio	17.89x
P/B ratio	3.09x
P/E ratio	27.71x
P/FCF ratio	19.87x
P/OCF ratio	17.38x
P/S ratio	1.02x
Price/EBITDA ratio	17.1x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	4.77%
EBITDA margin	5.97%
Effective tax rate	17.18%
FCF margin	5.13%
Gross margin	12.46%
Operating margin	4.77%
Pretax margin	4.58%
Profit margin	3.71%
Profit per employee	EUR 26,036
Profitable quarters	26
Profitable years	12
Revenue per employee	EUR 700,915
ROA	4%
ROA (5Y)	4.49%
ROCE	8.96%
ROE	11.36%
ROE (5Y)	12.76%
ROIC	6.82%
ROIC (5Y)	8.61%
SBC / revenue	0.17%
Tax / revenue	0.79%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-17.39%
EPS growth (Q)	-24.86%
EPS growth (QoQ)	-28.41%
EPS growth 10Y	6.9%
EPS growth 3Y	-16.06%
EPS growth 5Y	-3.14%
EPS growth years	0
FCF growth	-26.21%
FCF growth (Q)	-55.85%
FCF growth (QoQ)	-76.84%
FCF growth 3Y	10.82%
FCF growth 5Y	-3.23%
Gross profit growth	10.7%
Gross profit growth (Q)	11.56%
Gross profit growth 3Y	5.96%
Gross profit growth 5Y	6.11%
Net income growth	-17.24%
Net income growth (Q)	-24.83%
Net income growth (QoQ)	-28.52%
Net income growth 3Y	-16.07%
Net income growth 5Y	-3%
Net income growth years	0
OCF growth	-23.71%
OCF growth (Q)	-44.21%
OCF growth (QoQ)	-68.15%
OCF growth 10Y	11.58%
OCF growth 3Y	7.48%
OCF growth 5Y	-3.34%
Operating income growth	-2.98%
Operating income growth (Q)	-21.15%
Operating income growth 3Y	4.05%
Operating income growth 5Y	2.8%
Revenue growth	6.39%
Revenue growth (Q)	6.96%
Revenue growth (QoQ)	0.06%
Revenue growth 10Y	4.24%
Revenue growth 3Y	5.09%
Revenue growth 5Y	3.25%
Revenue growth quarters	5
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -34.2M
Depreciation and amortization	EUR 55.6M
EBIT	EUR 221.4M
EBITDA	EUR 277M
EPS	EUR 3.46
Financing cash flow	EUR 48.5M
Free cash flow	EUR 238.3M
Free cash flow minus SBC	EUR 230.5M
Gross profit	EUR 578.5M
Income taxes	EUR 36.5M
Investing cash flow	EUR -350.8M
Net borrowing	EUR 196.6M
Net cash flow	EUR -29.8M
Net income	EUR 172.4M
Operating cash flow minus SBC	EUR 264.7M
Operating income	EUR 221.4M
Revenue	EUR 4.6B
Stock-based compensation	EUR 7.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.52
Book value per share	EUR 30.66
Debt / EBITDA	3.55
Debt / equity	0.78
Debt / FCF	5.04
Interest coverage	13.9
Long-term assets	EUR 2.4B
Long-term liabilities	EUR 937.9M
Net cash (debt)	EUR -1.2B
Net cash / market cap	-24.43%
Net debt / EBITDA	4.18
Net debt / equity	0.76
Net debt / FCF	4.86
Piotroski F-Score	6
Property, plant and equipment	EUR 517.3M
Shareholders' equity	EUR 1.5B
Tangible book value	EUR -19.4M
Tangible book value per share	EUR -0.39
Total assets	EUR 3.6B
Total cash	EUR 42.9M
Total debt	EUR 1.2B
Total liabilities	EUR 2.1B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.34
Current assets	EUR 1.2B
Current liabilities	EUR 1.1B
Current ratio	1.07
Inventory turnover	9.94
Net working capital	EUR 408.4M
Quick ratio	0.64
Working capital	EUR 78.6M
Working capital turnover	29.34

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.08%
Dividend growth	0%
Dividend growth years	0
Dividend payment date	2026-04-27
Dividend payment years	2
Dividend payout frequency	Annual
Dividend per share	EUR 2.72
Dividend yield	2.84%
Ex-dividend date	2026-04-23
Last dividend	EUR 2.72
Payout ratio	78.72%
Shareholder yield	2.76%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 91.78
1D price change	0.79%
1M price change	8.44%
1M total return	8.44%
1Y price change	-3.7%
1Y return CAGR	-0.9%
1Y total return	-0.9%
20-day SMA	EUR 91.66
200-day SMA	EUR 95.28
3M price change	2.43%
3M total return	2.43%
50-day SMA	EUR 89.51
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 112.60
52-week high date	2026-02-17
52-week low	EUR 85.60
52-week low date	2026-08-17
6M price change	1.44%
6M total return	1.44%
All-time high	EUR 112.60
All-time high date	2026-02-17
All-time low	EUR 85.60
All-time low date	2026-08-17
Average true range (ATR)	EUR 0.88
Average volume	0
Change from 52-week high	-14.92%
Change from 52-week low	11.92%
Change from all-time high	-15.59%
Change from all-time low	11.04%
Change from open	0.63%
Day's gap	0.16%
High price	EUR 95.80
Low price	EUR 95.20
Monthly RSI	0
Open price	EUR 95.20
Position in 52-week range	100%
Previous close	EUR 95.05
Price vs 150-day SMA	3.57%
Price vs 20-day SMA	3.7%
Price vs 200-day SMA	-0.24%
Price vs 50-day SMA	6.19%
Relative volume	20
RSI	68.2
Sharpe ratio	-0.15
Sortino ratio	0.11
Weekly RSI	55.74
YTD price change	-9.65%
YTD total return	-7.02%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	49.7M
Shares change (QoQ)	-0.03%
Shares change (YoY)	0.08%
Shares held by insiders	0.26%
Shares held by institutions	40.8%

Deeper analysis on VIE/GALE

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/GALE report

Is a complete VIE/GALE research report available?

No complete published report is available for vie/GALE (VIE/GALE) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/GALE (VIE/GALE)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/GALE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/GALE indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/GALE

Frequently asked questions